Partnership for Health

Research. Innovation. Translation.

The Consortium of Clinical Research and Innovation, Singapore (CRIS) strengthens synergies and
develops strategies for national-level clinical research and translation programmes.

These programmes include the Singapore Clinical Research Institute, National Health Innovation
Centre, Advanced Cell Therapy and Research Institute, Singapore, Precision Health Research,
Singapore, and the Singapore Translational Cancer Consortium.

Our Business Units

Singapore Clinical Research Institute

SCRI is the national academic research organisation dedicated to enhancing the standards of
clinical research and coordinating clinical trials.

Our Business Units

National Health Innovation Centre

The NHIC provides the publicly-funded clinical research sector of Singapore with translational
funding and strategic guidance.

Our Business Units

Advanced Cell Therapy and Research Institute, Singapore

ACTRIS aims to become the national and regional Centre of Excellence for discovery, process
development and manufacturing of cellular-based therapeutics across the broad spectrum of
immunotherapy and regenerative medicine.

Our Business Units

Precision Health Research, Singapore

PRECISE coordinates a whole-of-government effort to implement Singapore’s National Precision
Medicine strategy.

Our Business Units

Singapore Translational Cancer Consortium

STCC is a nationally-coordinated consortium to synergise cancer research capabilities in
Singapore.